|
ARL2BP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.66453525910038E-15 |
| Normal-vs-Stage2 |
3.54730000000636E-05 |
| Normal-vs-Stage3 |
1.50919999997168E-06 |
| Normal-vs-Stage4 |
7.562300E-03 |
| Stage1-vs-Stage2 |
4.690000E-01 |
| Stage1-vs-Stage3 |
7.376200E-02 |
| Stage1-vs-Stage4 |
7.874600E-01 |
| Stage2-vs-Stage3 |
4.890000E-01 |
| Stage2-vs-Stage4 |
4.358400E-01 |
| Stage3-vs-Stage4 |
2.288800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.5643002145066E-10 |
| Normal-vs-Asian |
1.171960E-01 |
| Caucasian-vs-AfricanAmerican |
9.205400E-01 |
| Caucasian-vs-Asian |
9.797000E-01 |
| AfricanAmerican-vs-Asian |
9.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.7663427104585E-12 |
| Male-vs-Female |
1.453550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5947999998378E-07 |
| Normal-vs-Extreme_Weight |
6.6401328879806E-12 |
| Normal-vs-Obese |
1.2019052419987E-11 |
| Normal-vs-Extreme_Obese |
1.275980E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.489220E-01 |
| Normal_Weight-vs-Obese |
4.266000E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.599800E-01 |
| Extreme_Weight-vs-Obese |
4.904600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.408800E-01 |
| Obese-vs-Extreme_Obese |
7.831800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.382090E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62847513252018E-12 |
| Normal-vs-Age(81-100Yrs) |
1.423110E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.673200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.243000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.076400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.598300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.944600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.692400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.5718000234699E-09 |
| Normal-VS-KIRP CIMP |
1.915790E-03 |
| Normal-VS-Unclassified PRCC |
1.84789999968515E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.617800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.238800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.643000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.054400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.067990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.762200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74220000004333E-06 |
| Normal-vs-N1 |
3.43920000256404E-08 |
| Normal-vs-N2 |
1.272600E-01 |
| N0-vs-N1 |
1.554210E-01 |
| N0-vs-N2 |
8.420800E-01 |
| N1-vs-N2 |
6.331800E-01 |
|
|
